Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic inflammatory diseases of the musculoskeletal system. Although it seems likely that these conditions have a different pathogenesis, the drugs used to treat them are the same. Our study used a cross-sectional clinical database to compare drug use and side-effect profile in these 2 diseases.

Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions / Helliwell, ; Philip, S; Taylor, ; William J., Lassere M; Rappo, J; Mielants, H; Van de Berghe, M; Zmierczak, Hg; de Vlam, K; Russell, A; Gladman, D; Schentag, C; Fournie, B; Dougados, M; Dernis, E; Gossec, L; Zerkak, D; Veale, D; Fitzgerald, O; O'Rourke, M; Hajjaj Hassouni, N; Bentalha, Nl; Taylor, W; Healy, P; Marchesoni, A; Salvarani, Carlo; Macchioni, P; Emilia, R; Lubrano, E; Olivieri, I; Kalla, Aa; Potts, J; Modi, G; Patel, N; Torre Alonso, Jc; Svensson, B; Lindqvist, U; Holmstrom, G; Theander, E; Dahlqvist, Sr; Alenius, Gm; Ek, K; Isdale, A; Mcgonagle, D; Holdsworth, J; Sharlala, H; Adebajo, A; Kay, L; Mchugh, N; Lewis, J; Owen, P; Barkham, N; Bejarano, V; Henry, J; Henshaw, K; Emery, P; Helliwell, P; Ibrahim, G; Ritchlin, C; Durham, R; Espinoza, Lr; Candia, L; Mease, P; Wang, L; Gunter, L.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 35:(2008), pp. 472-476.

Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions

SALVARANI, CARLO;
2008

Abstract

Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic inflammatory diseases of the musculoskeletal system. Although it seems likely that these conditions have a different pathogenesis, the drugs used to treat them are the same. Our study used a cross-sectional clinical database to compare drug use and side-effect profile in these 2 diseases.
2008
35
472
476
WOS:000253913300021
2-s2.0-40649117711
18203324
Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions / Helliwell, ; Philip, S; Taylor, ; William J., Lassere M; Rappo, J; Mielants, H; Van de Berghe, M; Zmierczak, Hg; de Vlam, K; Russell, A; Gladman, D; Schentag, C; Fournie, B; Dougados, M; Dernis, E; Gossec, L; Zerkak, D; Veale, D; Fitzgerald, O; O'Rourke, M; Hajjaj Hassouni, N; Bentalha, Nl; Taylor, W; Healy, P; Marchesoni, A; Salvarani, Carlo; Macchioni, P; Emilia, R; Lubrano, E; Olivieri, I; Kalla, Aa; Potts, J; Modi, G; Patel, N; Torre Alonso, Jc; Svensson, B; Lindqvist, U; Holmstrom, G; Theander, E; Dahlqvist, Sr; Alenius, Gm; Ek, K; Isdale, A; Mcgonagle, D; Holdsworth, J; Sharlala, H; Adebajo, A; Kay, L; Mchugh, N; Lewis, J; Owen, P; Barkham, N; Bejarano, V; Henry, J; Henshaw, K; Emery, P; Helliwell, P; Ibrahim, G; Ritchlin, C; Durham, R; Espinoza, Lr; Candia, L; Mease, P; Wang, L; Gunter, L.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 35:(2008), pp. 472-476.
Helliwell, ; Philip, S; Taylor, ; William J., Lassere M; Rappo, J; Mielants, H; Van de Berghe, M; Zmierczak, Hg; de Vlam, K; Russell, A; Gladman, D; Schentag, C; Fournie, B; Dougados, M; Dernis, E; Gossec, L; Zerkak, D; Veale, D; Fitzgerald, O; O'Rourke, M; Hajjaj Hassouni, N; Bentalha, Nl; Taylor, W; Healy, P; Marchesoni, A; Salvarani, Carlo; Macchioni, P; Emilia, R; Lubrano, E; Olivieri, I; Kalla, Aa; Potts, J; Modi, G; Patel, N; Torre Alonso, Jc; Svensson, B; Lindqvist, U; Holmstrom, G; Theander, E; Dahlqvist, Sr; Alenius, Gm; Ek, K; Isdale, A; Mcgonagle, D; Holdsworth, J; Sharlala, H; Adebajo, A; Kay, L; Mchugh, N; Lewis, J; Owen, P; Barkham, N; Bejarano, V; Henry, J; Henshaw, K; Emery, P; Helliwell, P; Ibrahim, G; Ritchlin, C; Durham, R; Espinoza, Lr; Candia, L; Mease, P; Wang, L; Gunter, L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1079845
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 58
social impact